Using compact brain sensors to identify early signs of Alzheimer's Disease
Digital biomarkers for Alzheimer's Disease with compact dual-mode brain sensing
This study is looking to create a new, easy way to spot early signs of Alzheimer's Disease by using a quick 15-minute brain scan, helping older adults keep track of their brain health and catch any issues sooner.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Arlington NIH-funded |
| Lab location | 1 site (Arlington, United States) |
| Project ID | NIH-10526163 on NIH RePORTER |
What this research studies
This research focuses on developing digital biomarkers to detect Alzheimer's Disease (AD) at an early stage using compact brain-sensing technology. By measuring brain activity through a 15-minute resting-state assessment, the study aims to identify changes in metabolic, hemodynamic, and electrophysiological functions associated with AD. The goal is to create a non-invasive method for monitoring brain health in older adults, which could lead to earlier diagnosis and intervention. Patients will be monitored using advanced sensors that can provide real-time data on brain function.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults who may be experiencing early signs of cognitive decline or have a family history of Alzheimer's Disease.
Not a fit: Patients who are in the advanced stages of Alzheimer's Disease or have other forms of dementia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and better management of Alzheimer's Disease, improving outcomes for patients.
How similar studies have performed: Other research has shown promise in using digital biomarkers for neurological conditions, indicating that this approach could be effective for Alzheimer's Disease as well.
Where this research is happening
Arlington, United States
- University of Texas Arlington — Arlington, United States (Active)
Researchers
- Principal investigator: Liu, Hanli — University of Texas Arlington
- Study coordinator: Liu, Hanli
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.